| Literature DB >> 26717568 |
Lívia Pinheiro Carvalho1, Luciana Di Thommazo-Luporini1, Mylène Aubertin-Leheudre2, José Carlos Bonjorno Junior3, Cláudio Ricardo de Oliveira3, Rafael Luís Luporini4, Renata Gonçalves Mendes1, Katiany Thais Lopes Zangrando1, Renata Trimer1, Ross Arena5, Audrey Borghi-Silva1.
Abstract
Impaired cardiorespiratory fitness (CRF) is a hallmark characteristic in obese and lean sedentary young women. Peak oxygen consumption (VO2peak) prediction from the six-minute step test (6MST) has not been established for sedentary females. It is recognized that lower-limb muscle strength and power play a key role during functional activities. The aim of this study was to investigate cardiorespiratory responses during the 6MST and CPX and to develop a predictive equation to estimate VO2peak in both lean and obese subjects. Additionally we aim to investigate how muscle function impacts functional performance. Lean (LN = 13) and obese (OB = 18) women, aged 20-45, underwent a CPX, two 6MSTs, and isokinetic and isometric knee extensor strength and power evaluations. Regression analysis assessed the ability to predict VO2peak from the 6MST, age and body mass index (BMI). CPX and 6MST main outcomes were compared between LN and OB and correlated with strength and power variables. CRF, functional capacity, and muscle strength and power were lower in the OB compared to LN (<0.05). During the 6MST, LN and OB reached ~90% of predicted maximal heart rate and ~80% of the VO2peak obtained during CPX. BMI, age and number of step cycles (NSC) explained 83% of the total variance in VO2peak. Moderate to strong correlations between VO2peak at CPX and VO2peak at 6MST (r = 0.86), VO2peak at CPX and NSC (r = 0.80), as well as between VO2peak, NSC and muscle strength and power variables were found (p<0.05). These findings indicate the 6MST, BMI and age accurately predict VO2peak in both lean and obese young sedentary women. Muscle strength and power were related to measures of aerobic and functional performance.Entities:
Mesh:
Year: 2015 PMID: 26717568 PMCID: PMC4699911 DOI: 10.1371/journal.pone.0145960
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Flow diagram representing sample recruitment and loss.
Recruitment, eligible subject’s assessment, sample loss and its causes and final studied sample. BMI, body mass index; FM, fat mass; LN, lean group; OB, obese group.
Anthropometric, demographic, body composition and muscle measures.
| LN (n = 13) | OB (n = 18) | |
|---|---|---|
|
| ||
| Age (y) | 32 ± 5 | 35 ± 5 |
| Body Mass (kg) | 57.2±5.0 | 112.6±22.8 |
| BMI (kg·m-2) | 21.6±2.0 | 42.2±6.6 |
|
| ||
| BF (%) | 29.1±3.3 | 47.9±3.3 |
| LM (%) | 67.4±3.1 | 43.4±16.1 |
| Thigh circumference (cm) | 52.5±3.2 | 72.5±9.3 |
| WHR | 0.75±0.05 | 0.84±0.07 |
|
| ||
| ASMI (kg.m-2) | 6.2±0.4 | 9.0±0.7 |
| LLM (kg) | 6.5±0.3 | 9.1±0.9 |
| PT (N.m) | 133.8±21.7 | 177.2±37.1 |
| PT/BM (N.m.kg-1) | 2.3±0.7 | 1.6±0.4 |
| PT/LW (N.m.kg-1) | 233.2±38.8 | 159.9±37.9 |
| PT/BMI (N.m.kg-1.m2) | 6.2±0.9 | 4.3±0.9 |
| AVG Power/BM (W.kg-1) | 1.0±0.2 | 0.7±0.2 |
| AVG Power/LW (W.kg-1) | 5.7±1.0 | 4.0±1.0 |
| TW/BM (J.kg-1) | 28.0±4.6 | 19.1±3.4 |
| TW/LW (J.kg-1) | 164.9±27.4 | 116.1±25.6 |
Data presented as mean ± SD. LN, lean group; OB, obese group; BMI, body mass index; BF, body fat mass; LM, lean body mass; WHR, Waist-to-hip ratio; ASMI, appendicular skeletal muscle mass index; LLM, appendicular lean mass of the dominant leg; PT, isometric extensor peak torque; BM, body mass; LW, leg weight; AVG, average; TW, extensor isokinetic total work.
* Intergroup differences between LN and OB, p<0.05.
Metabolic characteristics.
| LN (n = 13) | OB (n = 18) | |
|---|---|---|
| Fasting glucose (mmol/l) | 4.8±0.4 | 5.1±0.4 |
| Fasting insulin (μu/ml) | 6.4±2.3 | 14.4±7.1 |
| HOMA | 1.46±0.51 | 3.28±1.60 |
| IR (n/ngroup) | 0/13 | 7/13 |
| Total cholesterol (mmol/l) | 10.5±2.8 | 11.2±2.1 |
| HDL (mmol/l) | 3.2±0.7 | 2.6±0.4 |
| LDL (mmol/l) | 6.3±2.2 | 7.2±1.7 |
| VLDL (mmol/l) | 0.9±0.3 | 1.5±0.9 |
| Triglycerides (mmol/l) | 4.6±1.4 | 7.5±4.5 |
Data presented as mean ± SD. HOMA, homeostatic model assessment; IR, insulin resistant; HDL, high-density lipoprotein; LDL, low-density lipoprotein; VLDL, very low-density lipoprotein.
* Intergroup differences between LN and OB.
Variables measured at peak exercise: CPX and 6MST.
| CPX | 6MST | |||
|---|---|---|---|---|
| LN (n = 13) | OB (n = 9) | LN (n = 13) | OB(n = 9) | |
|
| ||||
| NSC (n) | _ | _ | 196±24 | 152±22 |
| Workload (W) | _ | _ | 275.4±42.2 | 412.5±69.4 |
|
| ||||
| VO2peak (mL.kg-1.min-1) | 32.4±4.2 | 21.2±3.1 | 24.9±3.7 | 17.6±3.1 |
| VO2peak rel (%) | _ | _ | 77±9 | 81±13 |
| VO2peak/NSC (mL.kg-1.min-1.n) | 0.13±0.01 | 0.12±0.04 | ||
| RER | 1.25±0.09 | 1.23±0.10 | 1.04±0.09 | 1.07±0.10 |
|
| ||||
| HR (bpm) | 181±12 | 176±11 | 163±15 | 159±15 |
| HR (%pred) | 102±6 | 101±5 | 92±8 | 90±9 |
| SBP (mmHg) | 154±23 | 199±30 | 140±13 | 179±25 |
| DBP (mmHg) | 79±9 | 96±21 | 67±12 | 80±14 |
|
| ||||
| Dyspnea | 7 (5;10) | 7.5 (3;10) | 3 (0.5;8) | 3.5 (0;10) |
| Leg fatigue | 4 (0;10) | 3 (0;10) | 3 (0;7) | 2 (0;10) |
Data are presented in mean±SD and median (min;max). CPX, cardiopulmonary exercise testing; 6MST, six-minute step test; LN, lean group; OB, obese group; NSC, number of step cycles; VO2peak, oxygen consumption at the peak of exercise; rel, oxygen consumption at 6MST relative to VO2peak at CPX; RER, respiratory exchange ratio; HR, heart rate; SBP, systolic blood pressure; DBP, diastolic blood pressure. Intergroup and intratest differences between
*LN and OB; and intragroup and inter-test differences between
# CPX and 6MST.
Fig 2Correlations for LN, OB and overall sample for VO2peak at CPX, VO2peak and NSC at 6MST.
Pearson’s coefficient correlations between cardiorespiratory fitness and functional main variables between (A) VO2peak at CPX and 6MST; (B) VO2peak at CPX and NSC; (C) VO2peak at 6MST and NSC. VO2peak, oxygen consumption at the peak of exercise; CPX, cardiopulmonary exercise testing; 6MST, six-minute step test; NSC, number of step cycles; OB, obese group; LN, lean group. Dashed line: OB; dotted line: LN; continuous line: LN and OB (overall sample).
Correlation coefficients between VO2peak at CPX, VO2peak at 6MST, 6MST performance (NSC) and body composition and muscle function variables.
| VO2peak CPX | VO2peak 6MST | NSC | p-value | |
|---|---|---|---|---|
| BF (%) | -0.74a | -0.57 | -0.58 | <0.001 |
| LM (%) | 0.70 | 0.54 | 0.62 | <0.05 |
| PT/BMI (N.m.kg-1.m2) | 0.74 | 0.64 | 0.67 | <0.001 |
| PT/BM (N.m.kg-1) | 0.77 | 0.69 | 0.71 | <0.001 |
| PT/LW (N.m.kg-1) | 0.76 | 0.68 | 0.72 | <0.001 |
| AVG power/BM (W.kg-1) | 0.54 | 0.54 | 0.50 | <0.001 |
| AVG power/LW (W.kg-1) | 0.58 | 0.52 | 0.60 | <0.001 |
| TW/BM (J.kg-1) | 0.75 | 0.70 | 0.73 | <0.001 |
| TW/LW (J.kg-1) | 0.67 | 0.67 | 0.69 | <0.001 |
VO2peak, oxygen consumption at the peak of exercise, in mL.kg-1.min-1; CPX, cardiopulmonary exercise testing; 6MST, six-minute step test; NSC, number of step cycles (n); BMI, body mass index; BF, body fat mass; LM, lean body mass; WHR, PT, isometric extensor peak torque; BM, body mass; LW, leg weight; AVG, average; TW, extensor isokinetic total work.
aSpearman’s coefficient correlation.